Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced that the U.S. Food and Drug Administration (FDA) has issued a “no questions” letter regarding the company’s conclusion that its flagship product, marketed as Bioalbumen®, is Generally Recognized As Safe (GRAS) under its conditions of use in a wide range of food and beverage applications. 

Read the full press release.